Literature DB >> 12176507

Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match.

C J Sonnenday1, L E Ratner, A A Zachary, J F Burdick, M D Samaniego, E Kraus, D S Warren, R A Montgomery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12176507     DOI： 10.1016/s0041-1345(02)03044-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Immunogenetics and immunology in transplantation.

Authors:  Andrea A Zachary; Dessislava Kopchaliiska; Annette M Jackson; Mary S Leffell
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 2.  Treatment options and strategies for antibody mediated rejection after renal transplantation.

Authors:  Matthew H Levine; Peter L Abt
Journal:  Semin Immunol       Date:  2011-09-21       Impact factor: 11.130

3.  Desensitisation strategies in high-risk children before kidney transplantation.

Authors:  Ankit Sharma; Anne M Durkan
Journal:  Pediatr Nephrol       Date:  2018-01-13       Impact factor: 3.714

4.  Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.

Authors:  E R Rodriguez; Diane V Skojec; Carmela D Tan; Andrea A Zachary; Edward K Kasper; John V Conte; William M Baldwin
Journal:  Am J Transplant       Date:  2005-11       Impact factor: 8.086

Review 5.  Renal transplantation in high-risk patients.

Authors:  Nicole A Weimert; Rita R Alloway
Journal:  Drugs       Date:  2007       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.